BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 34732423)

  • 21. Accuracy of serum pepsinogens I and II, gastrin-17 and anti-helicobacter pylori antibodies in histological diagnoses of atrophic gastritis.
    Irvani S; Hashemi MR; Moghadam KG; Saeidee S; Khavaran K; Najari O; Ranavardi M; Nasiri S; Salmasian H; Rohanizadegan M
    Minerva Gastroenterol Dietol; 2010 Mar; 56(1):13-7. PubMed ID: 20190719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study.
    Storskrubb T; Aro P; Ronkainen J; Sipponen P; Nyhlin H; Talley NJ; Engstrand L; Stolte M; Vieth M; Walker M; Agréus L
    Scand J Gastroenterol; 2008; 43(12):1448-55. PubMed ID: 18663663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of Serological Gastric Biopsy in Different Gastric Mucosal Lesions: an Observational Study.
    Dong Z; Zhang X; Chen X; Zhang J
    Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31414587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 'Serological biopsy' in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection.
    Di Mario F; Moussa AM; Caruana P; Merli R; Cavallaro LG; Cavestro GM; Dal Bò N; Iori V; Pilotto A; Leandro G; Franzè A; Rugge M
    Scand J Gastroenterol; 2003 Dec; 38(12):1223-7. PubMed ID: 14750641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical utility of serum pepsinogen levels as a screening test of atrophic gastritis].
    Chae H; Lee JH; Lim J; Kim M; Kim Y; Han K; Kang CS; Shim SI; Kim JI; Park SH
    Korean J Lab Med; 2008 Jun; 28(3):201-6. PubMed ID: 18594172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Helicobacter pylori Infection, Gastric Cancer and Gastropanel.
    Loor A; Dumitraşcu DL
    Rom J Intern Med; 2016 Sep; 54(3):151-156. PubMed ID: 27658162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
    Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
    Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Potentialities of a serological method in diagnosis of atrophic gastritis].
    Pimenov SI; Makarenko EV
    Ter Arkh; 2008; 80(2):15-21. PubMed ID: 18372589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers.
    Agréus L; Kuipers EJ; Kupcinskas L; Malfertheiner P; Di Mario F; Leja M; Mahachai V; Yaron N; van Oijen M; Perez Perez G; Rugge M; Ronkainen J; Salaspuro M; Sipponen P; Sugano K; Sung J
    Scand J Gastroenterol; 2012 Feb; 47(2):136-47. PubMed ID: 22242613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GastroPanel® Biomarker Assay: The Most Comprehensive Test for
    Syrjänen K; Eskelinen M; Peetsalu A; Sillakivi T; Sipponen P; Härkönen M; Paloheimo L; Mäki M; Tiusanen T; Suovaniemi O; DiMARIO F; Fan ZP
    Anticancer Res; 2019 Mar; 39(3):1091-1104. PubMed ID: 30842138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serological Biomarker Test (GastroPanel
    Paloheimo L; Tiusanen T; Suovaniemi O; SyrjÄnen K
    Anticancer Res; 2021 Feb; 41(2):811-819. PubMed ID: 33517286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulin G antibody against Helicobacter pylori is an accurate test for atrophic gastritis.
    Hung HH; Chen TS; Lin HC
    J Chin Med Assoc; 2010 Jul; 73(7):355-9. PubMed ID: 20688300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-Negative Anti-
    Inoue M; Sawada N; Goto A; Shimazu T; Yamaji T; Iwasaki M; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):420-426. PubMed ID: 31826914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
    Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
    Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research.
    Tong Y; Wu Y; Song Z; Yu Y; Yu X
    BMC Gastroenterol; 2017 Jul; 17(1):88. PubMed ID: 28728545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pepsinogen and gastrin in the noninvasive diagnosis of gastric atrophy. A case-control study in Peruvian population].
    Colarossi A; Inga R; Prochazka R; Reyes U; Bussalleu A; Barúa RL
    Rev Gastroenterol Peru; 2011; 31(2):110-5. PubMed ID: 21836650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The clinical significance of GastroPanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer].
    Adamczyk M; Peczek Ł; Rudnicki C; Nawrot B; Stec-Michalska K
    Pol Merkur Lekarski; 2013 Sep; 35(207):141-7. PubMed ID: 24224450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The optimal serum pepsinogen cut-off value for predicting histologically confirmed atrophic gastritis.
    Kim EH; Kang H; Park CH; Choi HS; Jung DH; Chung H; Park JC; Shin SK; Lee SK; Lee YC
    Dig Liver Dis; 2015 Aug; 47(8):663-8. PubMed ID: 26077884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Risk of gastric cancer dependent on serological markers of atrophic gastritis: cohort study].
    Reshetnikov OV; Openko TG; Simonova GI; Kurilovich SA; Maliushina SK; Ragino IuI; Voevoda MI
    Vopr Onkol; 2012; 58(5):644-8. PubMed ID: 23600281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.